The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, T.
Right arrow Articles by Tsubata, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, T.
Right arrow Articles by Tsubata, T.
The Journal of Immunology, 1998, 160: 4662-4665.
Copyright © 1998 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: The B Cell Surface Protein CD72 Recruits the Tyrosine Phosphatase SHP-1 upon Tyrosine Phosphorylation1

Takahiro Adachi*, Heinrich Flaswinkel2,{dagger}, Hidetaka Yakura{ddagger}, Michael Reth{dagger} and Takeshi Tsubata3,*

* Department of Immunology, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan; {dagger} Department of Molecular Immunology, Biology III, Freiburg University, Freiburg, Germany; and {ddagger} Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo, Japan


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
Activation signals of lymphocytes are negatively regulated by the membrane molecules carrying the immunoreceptor tyrosine-based inhibition motif (ITIM). Upon tyrosine phosphorylation, ITIMs recruit SH2-containing phosphatases such as SHP-1, resulting in down-modulation of cell activation. We showed that the cytoplasmic domain of the CD72 molecule carries an ITIM and is associated in vitro with SHP-1 upon tyrosine phosphorylation. Moreover, cross-linking of B cell Ag receptor (BCR) enhances both tyrosine phosphorylation of CD72 and association of CD72 with SHP-1 in B cell line WEHI-231. These results indicate that CD72 recruits SHP-1 upon tyrosine phosphorylation induced by BCR signaling, suggesting that CD72 is a negative regulator of BCR signaling.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Most lymphocyte activation signals such as those delivered via the Ag receptor involve phosphorylation of signaling molecules by specific kinases. The activation signals are negatively regulated by various membrane molecules such as the killer cell inhibitory receptor (KIR),4 CD94/NKG2, and Ly-49 in NK cells, the low-affinity Fc receptor for IgG (Fc{gamma}R)IIB and CD22 in B cells, ILT2 (LIR-1) in B cells and monocytes, ILT3 in myeloid cells, gp49 in NK and mast cells, and LAIR-1 expressed in the majority of leukocytes (1, 2, 3). Those molecules contain the conserved immunoreceptor tyrosine-based inhibition motif (ITIM) in the cytoplasmic domain (4, 5, 6). When the tyrosine residue in the ITIM is phosphorylated, the ITIM recruits Src homology 2 (SH2)-containing phosphatases, such as protein tyrosine phosphatase SHP-1, and SH2-containing inositol 5-phosphatase (SHIP) (7, 8, 9, 10, 11, 12). Those phosphatases have been shown to down-modulate the cell activation presumably by dephosphorylating the signaling molecules. NK cells express ITIM-containing molecules of two distinct families: KIR, gp49, and LAIR-1 are members of the Ig superfamily, while Ly-49 and CD94/NKG2 are type II membrane molecules carrying a C-type lectin domain (2, 3). Although B cells express members of the Ig superfamily carrying ITIMs such as Fc{gamma}RIIB, CD22, and ILT-2 (3), an inhibitory receptor carrying C-type lectin domain has not yet been identified.

CD72 (Lyb-2) is a 45-kDa type II membrane protein carrying a C-type lectin domain and is expressed on B lineage cells as a homodimer (13, 14, 15, 16). Treatment with anti-CD72 has been shown to augment the activation of B cells induced by B cell Ag receptor (BCR) signaling (17, 18, 19). Recently, we demonstrated that an anti-CD72 Ab blocks BCR-mediated cell death of mature B cells (20). These findings suggest that CD72 ligation modulates BCR signaling. Here, we demonstrate that the cytoplasmic domain of CD72 carries an ITIM and recruits SHP-1 upon tyrosine phosphorylation. Moreover, BCR signaling enhances phosphorylation of CD72 and its recruitment of SHP-1. Since it has been suggested that SHP-1 negatively regulates activation signals, including the one via BCR (1, 2, 3, 7, 9, 21, 22), BCR signaling may be negatively regulated by CD72.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Cells

The mouse B lymphoma cell line WEHI-231 was cultured as described previously (23). In some experiments, WEHI-231 was cultured with 10 µg/ml of F(ab')2 fragments of goat anti-mouse IgM Ab (ICN Pharmaceuticals, Aurora, OH) or anti-mouse CD72a mAb 9-6.1 (18). The CD72a cDNA was obtained from total RNA prepared from a DBA/2 spleen by RT-PCR using a set of primers (5'-CCGAATTCATGGCTGACGCTATCACG-3' and 5'-AAGCGGCCGCTATATCCGGTTCAGTTCAG-3' (15). The CD72a cDNA was subcloned into an expression vector, pMik-neo (a gift of Dr. K. Maruyama, Tokyo Medical and Dental University) (pMikCD72). Transfection of WEHI-231 was done as described previously (23).

In vitro phosphorylation and association of glutathione S-transferase (GST) fusion proteins

The cDNA encoding the cytoplasmic domain of CD72 was obtained by PCR with a set of primers (5'-CCGAATTCATGGCTGACGCTATCACG-3' and 5'-CCGTCGACGTTTTGCAAGCAGACCGT-3') and subcloned into the EcoRI-SalI sites of the pGEX vector (Pharmacia, Uppsala, Sweden), resulting in pGEX-CD72 coding for a GST-CD72 fusion protein. For constructing the pGEX-Y7, pGEX-Y32, and pGEX-Y39 expression plasmids encoding GST fusion proteins containing peptides surrounding Y7 (AITYADLRFV), Y32 (CEAYEDGELT), and Y39 (ELTYENVQVS), respectively, we synthesized oligonucleotide pairs encoding the peptides (5'-AATTCGCTATCACGTATGCAGACCTGCGCTTTGTGG-3' and 5'-TCGACCACAAAGCGCAGGTCTGCATACGTGATAGCG-3' for Y7; 5 '-AATTCTGTGAGGCCTATGAAGATGGGGAACTCACCG-3' and 5'-TCGACGGTGAGTTCCCCATCTTCATAGGCCTCACAG-3' for Y32; and 5'-AATTCGAACTCACCTACGAGAACGTGCAAGTGTCTG-3' and 5'-TCGACAGACACTTGCACGTTCTCGTAGGTGACTTCG-3' for Y39). Oligonucleotide pairs were annealed and inserted into the EcoRI-XhoI sites of the pGEX vector. The GST fusion protein (10 µg) were phosphorylated by incubation with Sf9 cell lysates containing Lyn or Syk in in vitro kinase buffer (24). The cDNA encoding murine SHP-1 (25) was generated from total RNA of WEHI-231 by RT-PCR using a set of primers (5'-CCGAATTCGAACCCCAGGATGGTGAGG-3' and 5'-AAGATCGACTCACTTCCTCTTGAGAGA-3') and subcloned into the EcoRI-SalI sites of the pBluescript vector. The 35S-labeled SHP-1 proteins were synthesized in the presence of L-[35S]methionine using TNT-coupled in vitro translation kit (Promega, Madison, WI) and incubated with phosphorylated or unphosphorylated GST fusion proteins together with glutathione-coupled beads (Pharmacia) for 30 min at 4°C. Proteins precipitated with glutathione-coupled beads were subjected to SDS-PAGE, and the 35S-labeled proteins were visualized by autoradiography.

Immunoprecipitation and Western blotting

Cell lysates were incubated with 5 µg of anti-CD72 mAb 9-6.1 or anti-CD22 mAb Lyb-8.2 (PharMingen, San Diego, CA) and 30 µl of protein G-Sepharose (Pharmacia), and immunoprecipitation was done as described previously (26). Immune complexes were subjected to SDS-PAGE. Western blotting was done using peroxidase-conjugated anti-phosphotyrosine mAb 4G10, rabbit anti-SHP-1 (Upstate Biotechnology, Lake Placid, NY), and anti-SHIP (a kind gift of Dr. J. V. Ravetch, Rockefeller University, New York, NY) or rabbit anti-CD72 Abs generated against GST-CD72.


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
The surrounding sequences of Y7 (ITYADL) in the cytoplasmic domain of CD72 completely match the consensus sequence of ITIM (V/IxYxxL/V). Since KIR ITIM has been shown to be phosphorylated by the Src family tyrosine kinase Lck (27), we examined whether the cytoplasmic domain of CD72 is phosphorylated in vitro by the Src family tyrosine kinase Lyn and the cytoplasmic tyrosine kinase Syk expressed in B cells. GST fusion proteins containing the cytoplasmic domain of CD72 (GST-CD72) were incubated with Sf9 cell lysates expressing either Lyn or Syk, and the phosphorylation of GST-CD72 was examined by Western blotting using anti-phosphotyrosine Ab. Whereas GST alone was not phosphorylated by Lyn or Syk (Fig. 1Go, lanes 3 and 5), GST-CD72 was phosphorylated by both tyrosine kinases (lanes 4 and 6), indicating that CD72 is a potential substrate of Lyn and Syk expressed in B cells.



View larger version (42K):
[in this window]
[in a new window]
  		FIGURE 1. Phosphorylation of CD72 fusion proteins by Lyn or Syk. Ten micrograms of GST (lanes 1, 3, and 5) or GST-CD72 fusion protein (lanes 2, 4, and 6) was incubated with the lysates of Sf9 cells infected with a baculovirus carrying lyn (lanes 3 and 4) or syk (lanes 5 and 6) in the in vitro kinase buffer (30) for 15 min at 37°C. Proteins were subjected to SDS-PAGE, followed by Western blotting. As a negative control, the same amount of untreated GST and GST-CD72 was analyzed in parallel (lane 1 and 2). Upper panel, The membrane was probed with anti-phosphotyrosine mAb 4G10. Lower panel, The SDS-polyacrylamide gel was stained with Coomassie brilliant blue.

 
Tyrosine-phosphorylated ITIMs have been shown to recruit SH2-containing phosphatases such as SHP-1 (1, 2, 7, 8, 9, 11, 12). To ask whether SHP-1 is able to associate with the cytoplasmic domain of CD72 upon tyrosine phosphorylation, we synthesized 35S-labeled SHP-1 by in vitro translation and incubated the phosphatase with GST-CD72 either unphosphorylated or phosphorylated by Lyn. Although equivalent amounts of phosphorylated or unphosphorylated GST-CD72 were incubated with SHP-1 (Fig. 2GoA), SHP-1 was coprecipitated with tyrosine-phosphorylated GST-CD72 but not by unphosphorylated GST-CD72 (Fig. 2GoB). This result indicates that the cytoplasmic tail of CD72 can bind to SHP-1 upon tyrosine phosphorylation as is the case for other membrane molecules carrying ITIMs (1, 2, 7, 8, 9, 11, 12).



View larger version (25K):
[in this window]
[in a new window]
  		FIGURE 2. Tyrosine-phosphorylated CD72 associates with SHP-1 in vitro. GST-CD72 was phosphorylated as described in the legend to Figure 1Go except that the reaction was prolonged to 30 min. A, GST-CD72 fusion proteins treated with Lyn or untreated were subjected to SDS-PAGE, followed by Western blotting using rabbit anti-mouse CD72 Abs. B, 35S-labeled SHP-1 proteins were incubated with either phosphorylated (lane 2) or unphosphorylated GST-CD72 (lane 1) together with glutathione-coupled beads for 30 min at 4°C. The beads were washed with PBS three times and incubated with SDS-PAGE sample buffer. Proteins were separated by SDS-PAGE. 35S-labeled proteins were visualized by autoradiography. C, GST-Y7 (lane 1), GST-Y32 (lane 2), GST-Y39 (lane 3), and GST-CD72 (lane 4) fusion proteins were incubated with Lyn and subsequently with 35S-labeled SHP-1. Proteins were precipitated with glutathione-coupled beads and subjected to SDS-PAGE. 35S-labeled proteins were visualized by autoradiography. D, GST-Y7 (lane 1), GST-Y32 (lane 2), and GST-Y39 (lane 3) fusion proteins were incubated with Lyn and subjected to SDS-PAGE, followed by Western blotting using 4G10 mAb.

 
Among three tyrosine residues in the cytoplasmic domain of CD72 (amino acid residues number 7, 32, and 39), surrounding sequences of Y7 fit to the consensus sequence of ITIM. Moreover, the sequences surrounding Y39 (LTYENV) are similar to the consensus sequence of ITIM. To determine the tyrosines responsible for association with SHP-1, we prepared GST fusion proteins containing peptides surrounding either Y7, Y32, or Y39. When the fusion proteins were incubated with Lyn, both Y7 and Y39, but not Y32, were phosphorylated (Fig. 2GoD). However, SHP-1 was coprecipitated with the GST fusion protein containing Y7, but not Y32 or Y39 (lanes 1–3, Fig. 2GoC). SHP-1 may thus associate with the ITIM surrounding Y7 but not the ITIM-like sequence containing Y39 upon phosphorylation.

To test whether the cytoplasmic domain of CD72 recruits SH2-containing phosphatases upon phosphorylation in vivo, we transfected the CD72a cDNA into the B lymphoma line WEHI-231 expressing CD72b but not CD72a. Cell lysates from positive transfectants (WEHI-CD72) were precipitated with anti-CD72 mAb (9-6.1) recognizing CD72a but not CD72b (28). Western blotting of the immunoprecipitates revealed that CD72 is weakly phosphorylated in untreated WEHI-CD72 (4G10 blot in Fig. 3Go). However, tyrosine phosphorylation of CD72 was not increased by treatment with anti-CD72 mAb (data not shown). Because 1) CD72 is comodulated with BCR (29), and 2) CD72 is phosphorylated in vitro by BCR-associated kinases Lyn and Syk (Fig. 1Go), we hypothesized that BCR cross-linking enhances phosphorylation of CD72. Indeed, treatment of WEHI-CD72 cells with F(ab')2 fragments of anti-IgM Abs enhanced tyrosine phosphorylation of CD72 together with other substrates coprecipitated with CD72 (4G10 blot in Fig. 3Go). We thus assessed whether SH2-containing phosphatases are coprecipitated with CD72 in BCR-cross-linked WEHI-CD72 cells. Because CD22 has been shown to be phosphorylated and recruit SHP-1 upon BCR cross-linking, we precipitated the lysates with anti-CD22 Ab in parallel as a positive control. In cell lysates prepared from untreated WEHI-CD72 cells, a small amount of SHP-1 was coprecipitated with CD72, whereas anti-CD22 failed to precipitate SHP-1 (anti-SHP-1 blot). When we treated WEHI-CD72 with anti-Ig, a markedly increased amount of SHP-1 was coprecipitated with CD72 or CD22 from the cell lysates, although equal amounts of cell lysates were tested. Indeed, almost the same amount of CD72 was precipitated from the lysates of anti-Ig-treated WEHI-CD72 as from the lysates of untreated WEHI-CD72 (anti-CD72 blot). Upon BCR cross-linking, CD72 appears to be phosphorylated less efficiently than CD22 (4G10 blot), presumably due to the fact that CD22 carries six tyrosines in the cytoplasmic tail whereas CD72 contains only three tyrosines. However, the amount of SHP-1 coprecipitated with CD72 in untreated and BCR-cross-linked WEHI-CD72 correlates with the extent of phosphorylation of CD72 (4G10 blot). It is therefore most likely that SHP-1 is recruited to CD72 upon phosphorylation in vivo as is the case for CD22. In contrast, we failed to detect SHIP in the anti-CD72 precipitates from WEHI-CD72 either untreated or treated with F(ab')2 fragments of anti-IgM, although a considerable amount of SHIP is expressed in WEHI-231 (data not shown). Thus, it is probable that CD72 does not recruit SHIP regardless of the phosphorylation of CD72. Taken together, tyrosine-phosphorylated CD72 may recruit SHP-1 but not SHIP.



View larger version (47K):
[in this window]
[in a new window]
  		FIGURE 3. BCR signaling enhances tyrosine phosphorylation of CD72 and its association with SHP-1. WEHI-CD72 cells were incubated with or without 10 µg/ml of F(ab')2 fragments of anti-IgM Abs ({alpha}µ) for 3 min in RPMI 1640 medium, washed with PBS, and lysed in Triton X-100 lysis buffer. The lysates were incubated with 5 µg of either anti-CD72 mAb or anti-CD22 mAb together with 30 µl of protein G-Sepharose. Immune complexes were collected by centrifugation, washed three times with PBS, separated by SDS-PAGE, and subjected to Western blotting with indicated Abs. The bands representing CD72, determined by probing the membrane with rabbit anti-mouse CD72, are indicated. Note that two bands represent CD72, presumably due to differences in the m.w. between CD72a and CD72b (28). CD72b, which forms a dimer with CD72a, may also be precipitated with anti-CD72a Ab.

 
We demonstrated that CD72 recruits SHP-1 upon tyrosine phosphorylation both in vitro and in vivo. The ITIM sequence containing Y7 is responsible for association with SHP-1, in agreement with the previous findings that phosphorylated ITIMs in other membrane molecules associate with SH2-containing phosphatases such as SHP-1 (1, 2, 3, 7, 8, 11, 12). We also demonstrated that BCR signaling enhances phosphorylation of CD72 and its association with SHP-1 in WEHI-231 cells. Because 1) CD72 is comodulated with BCR (29) and 2) BCR-associated kinases Lyn and Syk are able to phosphorylate CD72 (Fig. 1Go), BCR-associated kinases activated by BCR cross-linking may phosphorylate CD72. Tyrosine-phosphorylated CD72 may subsequently recruit SHP-1, resulting in down-modulation of cell activation induced by BCR signaling. CD72 may, therefore, negatively regulate the cell activation induced by BCR ligation. The negative regulation of CD72 on BCR signaling may be enhanced or suppressed by treatment with anti-CD72 Ab. Indeed, anti-CD72 Ab have been shown to modulate the BCR signaling, resulting in augmentation of activation and abrogation of cell death in BCR-cross-linked B cells (17, 18, 19, 20). CD22, an ITIM-containing member of the Ig superfamily, is also associated with BCR and recruits SHP-1 upon BCR cross-linking, resulting in down-modulation of B cell activation induced by BCR signaling (30). Moreover, treatment with anti-CD22 Ab enhances B cell activation by BCR signaling by perturbing the negative regulation by CD22. CD72 may thus play a similar role to CD22 in the regulation of B cell function. Since CD72 carries a C-type lectin domain, activation signals in B cells may be negatively regulated by members of both the Ig superfamily and the C-type lectin family, as is the case for NK cells (2, 3).


   Acknowledgments
 
We are grateful to Drs. J. V. Ravetch (Rockefeller University) and K. Maruyama (Tokyo Medical and Dental University) for reagents, Dr. E. O. Long (National Institute of Allergy and Infectious Diseases) for helpful discussion, and Ms. Y. Shimokawa for technical assistance.


   Footnotes
 
1 This work was supported in part by grants from the Ministry of Education, Science, Sports, and Culture of Japan, the Science and Technology Agency of Japan, and the Uehara Memorial Foundation. Back

2 Present address: Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, D-81675 Munich, Germany. Back

3 Address correspondence and reprint requests to Dr. Takeshi Tsubata, Department of Immunology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113, Japan. E-mail address: Back

4 Abbreviations used in this paper: KIR, killer cell inhibitory receptor; BCR, B cell Ag receptor; ITIM, immunoreceptor tyrosine-based inhibition motif; GST, glutathione S-transferase; SH2, Src homology 2; SHIP, SH2-containing inositol 5-phosphatase. Back

Received for publication December 18, 1997. Accepted for publication March 17, 1998.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Ravetch, J. V.. 1997. Fc receptors. Curr. Opin. Immunol. 9:121.[Medline]
  2. Long, E. O., N. Wagtmann. 1997. Natural killer cell receptors. Curr. Opin. Immunol. 9:344.[Medline]
  3. Yokoyama, W. M.. 1997. What goes up must come down: the emerging spectrum of inhibitory receptors. J. Exp. Med. 186:1803.[Free Full Text]
  4. Amigorena, S., C. Bonnerot, J. R. Drake, D. Choquet, W. Hunziker, J. G. Guillet, P. Webster, C. Sautes, I. Mellman, W. H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808.[Abstract/Free Full Text]
  5. Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M. C. Nussenzweig, J. V. Ravetch. 1994. A 13-amino-acid motif in the cytoplasmic domain of Fc {gamma}RIIB modulates B-cell receptor signalling. Nature 368:70.[Medline]
  6. Thomas, M. L.. 1995. Of ITAMs and ITIMs: turning on and off the B cell antigen receptor. J. Exp. Med. 181:1953.[Free Full Text]
  7. Doody, G. M., L. B. Justement, C. C. Delibrias, R. J. Matthews, J. Lin, M. L. Thomas, D. T. Fearon. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242.[Abstract/Free Full Text]
  8. Campbell, M. A., N. R. Klinman. 1995. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur. J. Immunol. 25:1573.[Medline]
  9. D’Ambrosio, D., K. L. Hippen, S. A. Minskoff, I. Mellman, G. Pani, K. A. Siminovitch, J. C. Cambier. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc{gamma}RIIB1. Science 268:293.[Abstract/Free Full Text]
  10. Ono, M., S. Bolland, P. Tempst, J. V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc{gamma}RIIB. Nature 383:263.[Medline]
  11. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77.[Medline]
  12. Olcese, L., P. Lang, F. Vely, A. Cambiaggi, D. Marguet, M. Blery, K. L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J. C. Cambier, E. Vivier. 1996. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156:4531.[Abstract]
  13. Sato, H., E. A. Boyes. 1976. A new alloantigen expressed selectively on B cells: the Lyb-2 system. Immunogenetics 3:565.
  14. Tung, J.-S., J. Michaelson, H. Sato, E. S. Vittera, E. A. Boyes. 1977. Properties of the Lyb-2 molecule. Immunogenetics 5:485.
  15. Nakayama, E., H. I. von, J. R. Parnes. 1989. Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation. Proc. Natl. Acad. Sci. USA 86:1352.[Abstract/Free Full Text]
  16. Robinson, W. H., M. M. Landolfi, H. Schafer, J. R. Parnes. 1993. Biochemical identity of the mouse Ly-19.2 and Ly-32.2 alloantigens with the B cell differentiation antigen Lyb-2/CD72. J. Immunol. 151:4764.[Abstract]
  17. Subbarao, B., D. E. Mosier. 1984. Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies. J. Exp. Med. 159:1796.[Abstract/Free Full Text]
  18. Yakura, H., I. Kawabata, T. Ashida, F. W. Shen, M. Katagiri. 1986. A role for Lyb-2 in B cell activation mediated by a B cell stimulatory factor. J. Immunol. 137:1475.[Abstract]
  19. Kamal, M., A. Katira, J. Gordon. 1991. Stimulation of B lymphocytes via CD72 (human Lyb-2). Eur. J. Immunol. 21:1419.[Medline]
  20. Nomura, T., H. Han, M. C. Howard, H. Yagita, H. Yakura, T. Honjo, T. Tsubata. 1996. Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice. Int. Immunol. 8:867.[Abstract/Free Full Text]
  21. Cyster, J. G., C. C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2:13.[Medline]
  22. Pani, G., M. Kozlowski, J. C. Cambier, G. B. Mills, K. A. Siminovitch. 1995. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181:2077.[Abstract/Free Full Text]
  23. Tsubata, T., J. Wu, T. Honjo. 1993. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364:645.[Medline]
  24. Flaswinkel, H., M. Reth. 1994. Dual role of the tyrosine activation motif of the Ig-{alpha} protein during signal transduction via the B cell antigen receptor. EMBO J. 13:83.[Medline]
  25. Shen, S. H., L. Bastien, B. I. Posner, P. Chretien. 1991. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 352:736.[Medline]
  26. Adachi, T., W. W. Schamel, K. M. Kim, T. Watanabe, B. Becker, P. J. Nielsen, M. Reth. 1996. The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. EMBO J. 15:1534.[Medline]
  27. Binstadt, B. A., K. M. Brumbaugh, C. J. Dick, A. M. Scharenberg, B. L. Williams, M. Colonna, L. L. Lanier, J. P. Kinet, R. T. Abraham, P. J. Leibson. 1996. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5:629.[Medline]
  28. Robinson, W. H., H. Ying, M. C. Miceli, J. R. Parnes. 1992. Extensive polymorphism in the extracellular domain of the mouse B cell differentiation antigen Lyb-2/CD72. J. Immunol. 149:880.[Abstract]
  29. Jamin, C., C. R. Le, J. O. Pers, M. Dueymes, P. M. Lydyard, P. Youinou. 1997. Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells. Int. Immunol. 9:1001.[Abstract/Free Full Text]
  30. Cyster, J. G., C. C. Goodnow. 1997. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 6:509.[Medline]



This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
E. O. Lobo, Z. Zhang, and J. E. Shively
Pivotal Advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner
J. Leukoc. Biol., August 1, 2009; 86(2): 205 - 218.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. J. Gross, J. R. Lyandres, A. K. Panigrahi, E. T. L. Prak, and A. L. DeFranco
Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance
J. Immunol., May 1, 2009; 182(9): 5382 - 5392.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. J.A. Korporaal, C. A. Koekman, S. Verhoef, D. E. van der Wal, M. Bezemer, M. Van Eck, and J.-W. N. Akkerman
Downregulation of Platelet Responsiveness Upon Contact With LDL by the Protein-Tyrosine Phosphatases SHP-1 and SHP-2
Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 372 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. F. Brass, L. Zhu, and T. J. Stalker
Novel Therapeutic Targets at the Platelet Vascular Interface
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): s43 - s50.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Sato, T. Adachi, and T. Tsubata
Augmentation of Signaling through BCR Containing IgE but not That Containing IgA Due to Lack of CD22-Mediated Signal Regulation
J. Immunol., March 1, 2007; 178(5): 2901 - 2907.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Zhu, W. Bergmeier, J. Wu, H. Jiang, T. J. Stalker, M. Cieslak, R. Fan, L. Boumsell, A. Kumanogoh, H. Kikutani, et al.
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury
PNAS, January 30, 2007; 104(5): 1621 - 1626.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
N. Fujiwara, S. Hidano, H. Mamada, K. Ogasawara, D. Kitamura, M. D Cooper, N. Hozumi, C.-l. H Chen, and R. Goitsuka
A novel avian homologue of CD72, chB1r, down modulates BCR-mediated activation signals
Int. Immunol., May 1, 2006; 18(5): 775 - 783.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. H. Li, J. W. Tung, I. H. Tarner, A. L. Snow, T. Yukinari, R. Ngernmaneepothong, O. M. Martinez, and J. R. Parnes
CD72 Down-Modulates BCR-Induced Signal Transduction and Diminishes Survival in Primary Mature B Lymphocytes
J. Immunol., May 1, 2006; 176(9): 5321 - 5328.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Kumanogoh, T. Shikina, C. Watanabe, N. Takegahara, K. Suzuki, M. Yamamoto, H. Takamatsu, D. V. R. Prasad, M. Mizui, T. Toyofuku, et al.
Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment
Int. Immunol., October 1, 2005; 17(10): 1277 - 1282.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
N. Takegahara, A. Kumanogoh, and H. Kikutani
Semaphorins: a new class of immunoregulatory molecules
Phil Trans R Soc B, September 29, 2005; 360(1461): 1673 - 1680.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Y. Hitomi, N. Tsuchiya, A. Kawasaki, J. Ohashi, T. Suzuki, C. Kyogoku, T. Fukazawa, S. Bejrachandra, U. Siriboonrit, D. Chandanayingyong, et al.
CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B
Hum. Mol. Genet., December 1, 2004; 13(23): 2907 - 2917.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Ogimoto, G. Ichinowatari, N. Watanabe, N. Tada, K. Mizuno, and H. Yakura
Impairment of B cell receptor-mediated Ca2+ influx, activation of mitogen-activated protein kinases and growth inhibition in CD72-deficient BAL-17 cells
Int. Immunol., July 1, 2004; 16(7): 971 - 982.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. J. Lebbink, T. de Ruiter, A. Verbrugge, W. S. Bril, and L. Meyaard
The Mouse Homologue of the Leukocyte-Associated Ig-Like Receptor-1 Is an Inhibitory Receptor That Recruits Src Homology Region 2-Containing Protein Tyrosine Phosphatase (SHP)-2, but Not SHP-1
J. Immunol., May 1, 2004; 172(9): 5535 - 5543.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Kumanogoh and H. Kikutani
Immune semaphorins: a new area of semaphorin research
J. Cell Sci., September 1, 2003; 116(17): 3463 - 3470.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Hokazono, T. Adachi, M. Wabl, N. Tada, T. Amagasa, and T. Tsubata
Inhibitory Coreceptors Activated by Antigens But Not by Anti-Ig Heavy Chain Antibodies Install Requirement of Costimulation Through CD40 for Survival and Proliferation of B Cells
J. Immunol., August 15, 2003; 171(4): 1835 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. R. Whyburn, K. E. Halcomb, C. M. Contreras, C. A. Lowell, O. N. Witte, and A. B. Satterthwaite
Reduced Dosage of Bruton's Tyrosine Kinase Uncouples B Cell Hyperresponsiveness from Autoimmunity in lyn-/- Mice
J. Immunol., August 15, 2003; 171(4): 1850 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
I. Ishida, A. Kumanogoh, K. Suzuki, S. Akahani, K. Noda, and H. Kikutani
Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses
Int. Immunol., August 1, 2003; 15(8): 1027 - 1034.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Baba, N. Fusaki, N. Shinya, A. Iwamatsu, and N. Hozumi
Actin Tyrosine Dephosphorylation by the Src Homology 1-Containing Protein Tyrosine Phosphatase Is Essential for Actin Depolymerization After Membrane IgM Cross-Linking
J. Immunol., April 1, 2003; 170(7): 3762 - 3768.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
C. Wakabayashi, T. Adachi, J. Wienands, and T. Tsubata
A Distinct Signaling Pathway Used by the IgG-Containing B Cell Antigen Receptor
Science, December 20, 2002; 298(5602): 2392 - 2395.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Xu, S.-J. E. Beavitt, K. W. Harder, M. L. Hibbs, and D. M. Tarlinton
The Activation and Subsequent Regulatory Roles of Lyn and CD19 After B Cell Receptor Ligation are Independent
J. Immunol., December 15, 2002; 169(12): 6910 - 6918.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
C. H. Nielsen and R. G. Q. Leslie
Complement's participation in acquired immunity
J. Leukoc. Biol., August 1, 2002; 72(2): 249 - 261.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Kumanogoh, K. Suzuki, E. Ch'ng, C. Watanabe, S. Marukawa, N. Takegahara, I. Ishida, T. Sato, S. Habu, K. Yoshida, et al.
Requirement for the Lymphocyte Semaphorin, CD100, in the Induction of Antigen-Specific T Cells and the Maturation of Dendritic Cells
J. Immunol., August 1, 2002; 169(3): 1175 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Mizuno, Y. Tagawa, K. Mitomo, N. Watanabe, T. Katagiri, M. Ogimoto, and H. Yakura
Src Homology Region 2 Domain-Containing Phosphatase 1 Positively Regulates B Cell Receptor-Induced Apoptosis by Modulating Association of B Cell Linker Protein with Nck and Activation of c-Jun NH2-Terminal Kinase
J. Immunol., July 15, 2002; 169(2): 778 - 786.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
G. Bismuth and L. Boumsell
Controlling the Immune System Through Semaphorins
Sci. Signal., April 16, 2002; 2002(128): re4 - re4.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Bellon, F. Kitzig, J. Sayos, and M. Lopez-Botet
Mutational Analysis of Immunoreceptor Tyrosine-Based Inhibition Motifs of the Ig-Like Transcript 2 (CD85j) Leukocyte Receptor
J. Immunol., April 1, 2002; 168(7): 3351 - 3359.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Gary-Gouy, J. Harriague, A. Dalloul, E. Donnadieu, and G. Bismuth
CD5-Negative Regulation of B Cell Receptor Signaling Pathways Originates from Tyrosine Residue Y429 Outside an Immunoreceptor Tyrosine-Based Inhibitory Motif
J. Immunol., January 1, 2002; 168(1): 232 - 239.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Watanabe, A. Kumanogoh, W. Shi, K. Suzuki, S. Yamada, M. Okabe, K. Yoshida, and H. Kikutani
Enhanced Immune Responses in Transgenic Mice Expressing a Truncated Form of the Lymphocyte Semaphorin CD100
J. Immunol., October 15, 2001; 167(8): 4321 - 4328.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. Chen, W. Zimmermann, J. Parker, I. Chen, A. Maeda, and S. Bolland
Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals
J. Leukoc. Biol., August 1, 2001; 70(2): 335 - 340.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H.-J. Wu, C. Venkataraman, S. Estus, C. Dong, R. J. Davis, R. A. Flavell, and S. Bondada
Positive Signaling Through CD72 Induces Mitogen-Activated Protein Kinase Activation and Synergizes with B Cell Receptor Signals to Induce X-Linked Immunodeficiency B Cell Proliferation
J. Immunol., August 1, 2001; 167(3): 1263 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Goitsuka, H. Mamada, D. Kitamura, M. D. Cooper, and C.-l. H. Chen2
Genomic Structure and Transcriptional Regulation of the Early B Cell Gene chB1
J. Immunol., August 1, 2001; 167(3): 1454 - 1460.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
X. Wang, A. Kumanogoh, C. Watanabe, W. Shi, K. Yoshida, and H. Kikutani
Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses
Blood, June 1, 2001; 97(11): 3498 - 3504.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. L. Henshall, K. L. Jones, R. Wilkinson, and D. E. Jackson
Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatases, SHP-1 and SHP-2, Are Required for Platelet Endothelial Cell Adhesion Molecule-1/CD31-Mediated Inhibitory Signaling
J. Immunol., March 1, 2001; 166(5): 3098 - 3106.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
J. V. Ravetch and L. L. Lanier
Immune Inhibitory Receptors
Science, October 6, 2000; 290(5489): 84 - 89.
[Abstract] [Full Text]

Home page
 Int ImmunolHome page
H. Ochi and T. Watanabe
Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity
Int. Immunol., October 1, 2000; 12(10): 1417 - 1423.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Mizuno, Y. Tagawa, K. Mitomo, Y. Arimura, N. Hatano, T. Katagiri, M. Ogimoto, and H. Yakura
Src Homology Region 2 (SH2) Domain-Containing Phosphatase-1 Dephosphorylates B Cell Linker Protein/SH2 Domain Leukocyte Protein of 65 kDa and Selectively Regulates c-Jun NH2-Terminal Kinase Activation in B Cells
J. Immunol., August 1, 2000; 165(3): 1344 - 1351.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Yang, Z. Cheng, T. Niu, X. Liang, Z. J. Zhao, and G. W. Zhou
Structural Basis for Substrate Specificity of Protein-tyrosine Phosphatase SHP-1
J. Biol. Chem., February 11, 2000; 275(6): 4066 - 4071.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Adachi, C. Wakabayashi, T. Nakayama, H. Yakura, and T. Tsubata
CD72 Negatively Regulates Signaling Through the Antigen Receptor of B Cells
J. Immunol., February 1, 2000; 164(3): 1223 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-J. Jin, C.-L. Yu, and S. J. Burakoff
Human 70-kDa SHP-1L Differs from 68-kDa SHP-1 in Its C-terminal Structure and Catalytic Activity
J. Biol. Chem., October 1, 1999; 274(40): 28301 - 28307.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-J. Jin, C.-L. Yu, and S. J. Burakoff
Human 70-kDa SHP-1L Differs from 68-kDa SHP-1 in Its C-terminal Structure and Catalytic Activity
J. Biol. Chem., October 1, 1999; 274(40): 99999 - 99999.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J. Zhang, A.-K. Somani, D. Yuen, Y. Yang, P. E. Love, and K. A. Siminovitch
Involvement of the SHP-1 Tyrosine Phosphatase in Regulation of T Cell Selection
J. Immunol., September 15, 1999; 163(6): 3012 - 3021.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Bruhns, P. Marchetti, W. H. Fridman, E. Vivier, and M. Daeron
Differential Roles of N- and C-Terminal Immunoreceptor Tyrosine-Based Inhibition Motifs During Inhibition of Cell Activation by Killer Cell Inhibitory Receptors
J. Immunol., March 15, 1999; 162(6): 3168 - 3175.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-j. Xu, R. Zhao, and Z. J. Zhao
Identification and Characterization of Leukocyte-associated Ig-like Receptor-1 as a Major Anchor Protein of Tyrosine Phosphatase SHP-1 in Hematopoietic Cells
J. Biol. Chem., June 2, 2000; 275(23): 17440 - 17446.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Lesourne, P. Bruhns, W. H. Fridman, and M. Daeron
Insufficient Phosphorylation Prevents Fcgamma RIIB from Recruiting the SH2 Domain-containing Protein-tyrosine Phosphatase SHP-1
J. Biol. Chem., February 23, 2001; 276(9): 6327 - 6336.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Adachi, J. Wienands, C. Wakabayashi, H. Yakura, M. Reth, and T. Tsubata
SHP-1 Requires Inhibitory Co-receptors to Down-modulate B Cell Antigen Receptor-mediated Phosphorylation of Cellular Substrates
J. Biol. Chem., July 6, 2001; 276(28): 26648 - 26655.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, T.
Right arrow Articles by Tsubata, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, T.
Right arrow Articles by Tsubata, T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS